Femalegra is a brand of sildenafil citrate formulated to help women experiencing female sexual arousal disorder (FSAD) or hypoactive sexual desire disorder. FSAD is characterized by insufficient genital blood flow, decreased lubrication, and difficulty achieving or sustaining arousal during sexual activity. Sildenafil citrate, widely known for its role in male erectile dysfunction medications, works by inhibiting phosphodiesterase type 5 (PDE5), thereby increasing levels of cyclic guanosine monophosphate (cGMP) and enhancing blood flow to the genital tissues. In women, improved blood flow to the clitoral and vaginal tissues can enhance arousal, lubrication and sensitivity.
To use Femalegra, a woman should swallow one tablet with water approximately 30 to 45 minutes before anticipated sexual activity. It is important not to exceed one dose in a 24‑hour period. The medication is intended for women diagnosed with FSAD and should be taken only under the guidance of a healthcare professional. Femalegra is not intended for women who are pregnant or breastfeeding. Women with cardiovascular disease, severe liver or kidney disease, or those taking nitrates or other medications that interact with sildenafil should discuss the risks and benefits with their doctor before use.
Common side effects of Femalegra are similar to those of sildenafil in men and may include headache, facial flushing, nasal congestion, indigestion, or mild dizziness. Less common adverse reactions include vision changes, ringing in the ears or palpitations. If any severe side effects occur, such as sudden vision or hearing loss, chest pain or a prolonged headache, discontinue use and seek medical attention immediately. Because research on sildenafil for women is ongoing, its effectiveness and safety profile may vary among individuals.
For women experiencing sexual arousal issues who have been evaluated by a healthcare provider, Femalegra may offer a potential option to enhance arousal and sexual satisfaction when used responsibly.
To use Femalegra, a woman should swallow one tablet with water approximately 30 to 45 minutes before anticipated sexual activity. It is important not to exceed one dose in a 24‑hour period. The medication is intended for women diagnosed with FSAD and should be taken only under the guidance of a healthcare professional. Femalegra is not intended for women who are pregnant or breastfeeding. Women with cardiovascular disease, severe liver or kidney disease, or those taking nitrates or other medications that interact with sildenafil should discuss the risks and benefits with their doctor before use.
Common side effects of Femalegra are similar to those of sildenafil in men and may include headache, facial flushing, nasal congestion, indigestion, or mild dizziness. Less common adverse reactions include vision changes, ringing in the ears or palpitations. If any severe side effects occur, such as sudden vision or hearing loss, chest pain or a prolonged headache, discontinue use and seek medical attention immediately. Because research on sildenafil for women is ongoing, its effectiveness and safety profile may vary among individuals.
For women experiencing sexual arousal issues who have been evaluated by a healthcare provider, Femalegra may offer a potential option to enhance arousal and sexual satisfaction when used responsibly.
0